End of treatment ‐ homozygous major · people who smoke
Active NRT showed no clear difference in end of treatment ‐ homozygous major compared with placebo ‐ rs2036527 ‐ non‐Hispanic black or African American (low certainty).
1 finding from 1 review
End of treatment ‐ heterozygous or homozygous minor · people who smoke
Active NRT showed no clear difference in end of treatment ‐ heterozygous or homozygous minor compared with placebo ‐ rs2036527 ‐ non‐Hispanic black or African American (moderate certainty).
1 finding from 1 review
Intervention not reported
PIPP score intra procedure Range of scale 0‐21 for infants < 28 weeks PMA and 0‐18 for infants > 36 weeks PMA A lower score = less pain (Stevens 1996; Stevens 2014a) · neonates with pain associated with orogastric tube insertion
1 finding from 1 review
Intervention not reported
PIPP score 30 seconds post procedure Range of scale 0‐21 for infants < 28 weeks PMA and 0‐18 for infants > 36 weeks PMA A lower score = less pain (Stevens 1996; Stevens 2014a) · neonates with pain associated with orogastric tube insertion
1 finding from 1 review
Intervention not reported
PIPP score 1 min post procedure Range of scale 0‐21 for infants < 28 weeks PMA and 0‐18 for infants > 36 weeks PMA A lower score = less pain (Stevens 1996; Stevens 2014a) · neonates with pain associated with orogastric tube insertion
1 finding from 1 review
Proportion of participants with complete cure · children infected with Trichophyton
Complete cure for ketoconazole showed no clear difference in proportion of participants with complete cure compared with griseofulvin (low certainty).
2 findings from 1 review
Proportion of participants with complete cure · children infected with Trichophyton
Complete cure for fluconazole showed no clear difference in the proportion of participants with complete cure compared with terbinafine (low certainty).
1 finding from 1 review
Proportion of participants with complete cure · children infected with Trichophyton
Complete cure for fluconazole showed no clear difference in proportion of participants with complete cure compared with itraconazole (low certainty).
1 finding from 1 review
Proportion of participants with complete cure · children infected with Trichophyton and Microsporum
It is very uncertain whether complete cure for itraconazole changes proportion of participants with complete cure compared with griseofulvin (very low certainty).
1 finding from 1 review
Proportion of participants with complete cure · children infected with Trichophyton
Complete cure for itraconazole showed no clear difference in proportion of participants with complete cure compared with terbinafine (low certainty).
1 finding from 1 review
Short‐term improvement Scale used (range; lower is better): Clinical Global Impression (1 to 7) Agoraphobic Cognitions Questionnaire (1 to 70) Panic Disorder Severity Scale (0 to 28) Brief Scale for Anxiety (0 to 60) · adults with panic disorder
1 finding from 1 review
Short‐term remission · adults with panic disorder
All psychological therapies showed no clear difference in short‐term remission compared with tricyclic antidepressants (low certainty).
1 finding from 1 review
Short‐term response · adults with panic disorder
All psychological therapies showed no clear difference in short‐term response compared with tricyclic antidepressants (low certainty).
1 finding from 1 review
Leaving the study early · adults with panic disorder
All psychological therapies showed no clear difference in dropouts for any reason compared with tricyclic antidepressants (low certainty).
1 finding from 1 review
Long‐term remission/response · adults with panic disorder
1 finding from 1 review
Acceptability. Participants experiencing troublesome adverse effects of any nature · depression in adults
S‐adenosyl methionine as monotherapy may leads to lower acceptability. Participants experiencing troublesome adverse effects… compared with tricyclic antidepressant agent (low certainty).
1 finding from 1 review
Change in depressive symptoms · depression in adults
1 finding from 1 review
Secondary outcome: acceptability of treatment · depression in adults
It is very uncertain whether S‐adenosyl methionine as monotherapy changes acceptability Participants dropping out of treatment during the… compared with tricyclic antidepressant agent (very low certainty).
1 finding from 1 review
> 50% reduction in depressive symptoms · depression in adults
It is very uncertain whether S‐adenosyl methionine as monotherapy changes proportions of participants responding to treatment ≥ 50% reduction… compared with tricyclic antidepressant agent (very low certainty).
1 finding from 1 review
Depression remission · depression in adults
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found